Veriheal

APRIL 11, 2024

Medical cannabis is more popular than ever before, with 38 states having legalized some form of it for various health conditions. This data aligns with Americans’ rising acceptance of cannabis. The most popular qualifying conditions continue to be chronic pain and PTSD, some of which may be related to the pandemic.

Patients 96

Patients Chronic Pain Marijuana Conditions 96

NORML

APRIL 30, 2020

The call for comments, posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management. percent in 2016).”

Chronic Pain 346

Chronic Pain Clinical Trials Data Patients 346

The Cannigma

JANUARY 16, 2021

When you walk into a hardware store, pharmacy, or even a liquor store, if you don’t know exactly what product will meet your needs there’s someone educated enough to point you to the right product and the data to back up that recommendation, says Tyler Dautrich, COO of Releaf. Edited and mixed by Michael Schaeffer Omer-Man.

Data 100

Data Research and Development Patients Strains 100

SpeedWeed

MARCH 14, 2021

Big data and technology have become critical to a wide variety of industries in recent years, and the cannabis industry is no exception. Through advanced data collection and the application of sophisticated algorithms, usable data is now available to help marijuana businesses: Predict trends. Met consumer demands. Reduce costs.

Data 52

Data Research and Development Marijuana Collective 52

Cannabis Law Report

DECEMBER 11, 2021

The UK’s first and highest-rated medical cannabis clinic, Sapphire Medical Clinics , has today announced that it is reducing the cost of its consultations and appointments for patients enrolled through the Sapphire Access Scheme. The Sapphire Access Scheme will be open to an additional 2,000 patients in the UK.

Access 52

Access Patients Chronic Pain Treatment 52

Cannabis Law Report

AUGUST 20, 2022

CHICAGO — Governor JB Pritzker and the Illinois Department of Financial and Professional Regulation (IDFPR) today issued three additional Conditional Adult Use Dispensing Organization Licenses to applicants selected in lotteries held in the summer of 2021. Additional information on these resources and how to access them can be found here.

Conditions 52

Conditions Dispensary Programs Business 52

NORML

JANUARY 31, 2019

Seventy-five percent of military veterans say that they would consider using either “cannabis or cannabinoid products as a treatment option,” according to member survey data compiled by the group Iraq and Afghanistan Veterans of America (IAVA). The organization represents over 400,000 veterans nationwide.

Clinical Trials 197

Clinical Trials Chronic Pain Data Treatment 197

NORML

MAY 26, 2020

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain.

Clinical Trials 256

Clinical Trials Chronic Pain Cannabinoids Patients 256

Cannabis Law Report

AUGUST 23, 2022

Spotlight PA sought that data to better understand the impact of the agency’s unusual and controversial decision to endorse cannabis as a treatment option for opioid use disorder. Qualifying conditions include anxiety disorders, severe chronic pain and epilepsy. It’s not clear whether the Department of Health will provide the data.

Data 52

Data Treatment Patients Chronic Pain 52

Cannabis Law Report

JUNE 23, 2021

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). PROGRAMME.and.ABSTRACTS. Patient-reported outcomes. Peer-reviewed analysis.

Cannabinoids 59

Cannabinoids Data Chronic Pain Sleep 59

Cannabis Law Report

JANUARY 6, 2022

Oregon’s developing psilocybin program is nothing short of revolutionary and provides an opportunity to investigate the potential of psilocybin in treating a myriad of mental health conditions. The FDA will likely refer to this data as it considers formal approval for psilocybin therapy and products. Threat to Patient Access in Oregon.

Access 52

Access Patients Research and Development Treatment 52

Cannabis Law Report

AUGUST 14, 2019

Let’s take a closer look at five key ways big data and technology are directly impacting the industry. Big Data Streamlines the Marijuana Regulatory Process and Helps Close the Scientific Research Gap. Therefore, the growing marijuana market lacks the clinical data needed to help marijuana businesses create new and better products.

Data 45

Data Research and Development Marijuana Collective 45

NORML

JUNE 10, 2020

The agency’s call for comments, initially posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management. percent in 2016).”

Chronic Pain 246

Chronic Pain Therapy Patients Topical 246

NORML

NOVEMBER 25, 2019

Patients suffering from persistent pain conditions who frequently use cannabis are far less likely to use non-prescription opioids, according to longitudinal data published in the journal PLOS One.

Chronic Pain 282

Chronic Pain Patients Therapy Data 282

Cannabis Law Report

AUGUST 23, 2021

They announced that they’re ‘committed to ongoing transparency and will release additional datasets in the future’, such as data on Authorised Prescriber applications and the concentrations of active ingredients. Cannabis is currently used to treat a wide range of conditions.

Chronic Pain 105

Chronic Pain Concentrates Conditions Data 105

MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions. Image by Pfüderi from Pixabay.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

NewsMunchies

JULY 10, 2023

With the promise of lower costs and shorter development timelines, AI-enabled drug discovery holds major potential to increase the accessibility of drugs and to treat diseases and conditions. Using AI-powered medicine could allow for more effective treatment of conditions such as heart disease, cancer, and cystic fibrosis.

Treatment 58

Treatment Research and Development Pharmaceutical Microdosing 58

Medicinal Marijuana Association

FEBRUARY 10, 2024

Differentiate between fact and fiction by accessing trustworthy information. Implement research findings by consulting experts and translating data into practical actions. By analyzing these studies, you can gain insights into the effects of cannabis on various medical conditions, such as chronic pain, epilepsy, and anxiety.

Research and Development 52

Research and Development Data Chronic Pain Conditions 52

Veriheal

FEBRUARY 9, 2023

The data collected so far by the Turner Institute for Brain and Mental Health at Monash University in Australia suggests that psilocybin not only makes the process more comfortable but, as one participant described, MRIs become “magical.” All imaging and behavioral data will be accessible to the public after the study is complete.

Clinical Trials 91

Clinical Trials Research and Development Data Collective 91

The Cannigma

MARCH 14, 2023

Cancer, HIV, epilepsy and other serious conditions were the first accepted uses of cannabis in the United States. Many of the early medical cannabis states had strict lists of conditions for which cannabis could be legally used. And the process of adding additional conditions was often lengthy, difficult and mired in paternalism.

Policy 96

Policy Research and Development Conditions Consumption 96

Cannabis Law Report

AUGUST 2, 2021

The nearly 3,000 participant study will capture and publish the most comprehensive data ever collected on CBD product effectiveness from 13 commercially available U.S. Radicle ACES is Institutional Review Board (IRB) approved and will capture CBD effectiveness data directly from nearly 3,000 study participants.

CBD 105

CBD Data Sleep Clinical Trials 105

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).

Consumption 105

Consumption Patients Research and Development Data 105

Veriheal

SEPTEMBER 13, 2022

Grow rooms require ventilation, lights, environmental controls, and other optimal environmental conditions in order for cannabis plants to thrive. Research from New Frontier Data estimates that around 3 million people grow their own cannabis at home in the United States. Homegrown Cannabis Statistics: Supplies, Growers and Products .

Cultivation 108

Cultivation Data DEA Dispensary 108

Veriheal

DECEMBER 14, 2023

The participants also reported that medical marijuana has been beneficial for their various health conditions, which include chronic pain, anxiety, and insomnia. The results were pleasing – researchers found no significant difference in cognitive ability before and after participants consumed cannabis.

Chronic Pain 120

Chronic Pain Consumption Cannabis Marijuana 120

The Joint Blog

FEBRUARY 13, 2020

We think there is a lot of overlap between conditions for which medical marijuana can be used in managing symptoms and the types of illnesses that lead people to file workers’ compensation claims,” said study coauthor, Catherine Maclean, an associate professor in the economics department at Temple University in Philadelphia.

Access 32

Access Marijuana Data Policy 32

Cannabis Law Report

JUNE 23, 2021

Medicann is a premier cannabis-specialized clinic, providing patients with access to local specialist doctors and pharmacists that have experience prescribing cannabis-based medication. With a strong IP portfolio, RYAH gathers deep and insightful data on the complete patient session and formulation life cycle. About RYAH Group, Inc.

Programs 100

Programs Data Events Collective 100

Cannabis Law Report

AUGUST 24, 2022

New research from the University of Sydney’s Lambert Initiative finds most Australians are still medicating with illicit cannabis, although numbers accessing prescription products have risen dramatically. People using illicit products were more likely to be treating mental health or sleep conditions.

Medicine 52

Medicine Legalization Chronic Pain Access 52

Cannabis Law Report

MAY 10, 2022

More than half of all prescriptions for medicinal cannabis in Australia are written by doctors in Queensland, with prescriptions often given for conditions there is little evidence medicinal cannabis can treat, new research reveals. The researchers’ analysis found anxiety was the reason given for 16% of medicinal cannabis prescriptions.

Medicine 52

Medicine Clinical Trials Data Sleep 52

Cannabis Law Report

JUNE 1, 2021

Given the size and scale of the study, RYAH has developed a custom software solution, using OAuth API-integration to protect the privacy of the participants in the study, with the goal of enabling a fully integrated, patient feedback and data collection capability. About RYAH Group, Inc. RYAH Group, Inc.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Cannabis Law Report

JUNE 5, 2021

” Kulfas’ presentation began with some hard data, giving an account of the importance of regulating the activity in Argentina. Why does Argentina have the conditions to be an important producer in the cannabis and hemp industry? ley cáñamo argentina. ley cáñamo argentina. Employment: Generation of quality jobs.

Hemp 105

Hemp Research and Development Pharmaceutical Agriculture 105

Illinois News Joint

MAY 12, 2023

Another paragraph added, “During hours of operation, dispense all cannabis from the restricted access area, a drive-through window of the restricted access area, or a pickup location in close proximity to the restricted access area. Illinois has 17 such regions.

Packaging 99

Packaging Agriculture Cannabis Cultivation 99

Cannabis Law Report

SEPTEMBER 7, 2022

Since the legalisation of medical cannabis in the UK in 2018, there is little education surrounding medical cannabis and how it can help a large variety of conditions, should traditional medicine leave patients with an ‘unmet clinical need.’ . Cantourage Clinic is a leading medical cannabis clinic in the UK with a difference. .

Patients 52

Patients Conditions Treatment Education 52

Cannabis Law Report

DECEMBER 9, 2021

“Partnering with Fyllo reinforces our commitment to delivering innovative data solutions designed to enhance our clients’ audience reach strategies,” said Jay Baum , Chief Commercial Officer at Tremor Video. Learn more about Tremor Video’s data-driven audience solutions at www.tremorvideo.com. Traditional segments (e.g.

CBD 52

CBD Data Compliance Compliance 52

Veriheal

DECEMBER 9, 2021

Those who support cannabis have used the evidence of its ability to treat mental conditions like post-traumatic stress disorder (PTSD) to rebuke claims of a link between cannabis and mental illness. We found that recreational marijuana access was associated with a 6.29 Support From Other Studies. Singer et al.

Legalization 98

Legalization Research and Development Consumption Recreational 98

MMJ Recs

AUGUST 30, 2021

Since these beginnings in 2014, many other changes surrounding the use and possession of medical marijuana have been put into place in Missouri so the state can provide legal medical marijuana to patients suffering from a variety of approved conditions. Is medical marijuana being sold in Missouri yet?

Seed-To-Sale 98

Seed-To-Sale Business Marijuana Dispensary 98

Veriheal

AUGUST 15, 2022

The condition may also occur as a result of poor lifestyle habits, chronic disease, and depression. Data was pulled from 3,922 cannabis self-administration sessions with the help of this application. The sessions were logged by a total of 1,224 people who had access to the app. The Releaf App’s Role in the Fatigue Study.

Treatment 80

Treatment Research and Development Sativa Cannabinoids 80

Veriheal

JANUARY 1, 2024

Ohio’s Cannabis Landscape: Current Status and Future Outlook Ohio’s medical marijuana program, first launched in 2016 , brought legal access to patients managing certain debilitating conditions, but it took three years for dispensaries to open up due to regulatory challenges.

Recreational 101

Recreational Supply Chain Legislation Cannabis 101